viewer
On the 11th, the trial of Samsung Electronics Vice Chairman Lee Jae-yong, who was accused of illegal succession of Samsung Group’s management rights, will resume after five months. In addition, it will be decided on the same day whether or not to hold the Prosecutors’ Investigation Deliberation Committee, which Vice Chairman Lee requested to convene for the case of the suspected illegal administration of Propofol and to determine whether the investigation continues.
Part 25 of the Seoul Central District Court’s Criminal Agreement (Dr. Park Jeong-je and Deputy Judge Seong-su Kwon) will open the second trial preparation date for Lee and Samsung Group officials, who were handed over to trial on charges of violating the laws on the capital market and financial investment business. It is expected that the vice-chairman Lee will not appear in the court on the same day as there is no obligation for the defendant to attend the trial preparation date.
The prosecution said that the Samsung Group’s Future Strategy Office planned a merger between Samsung C&T and Cheil Industries for the stable succession of vice chairman Lee’s management rights, and passed 11 Samsung officials, including Vice Chairman Lee, to trial in September last year.
In October of the same year, the first trial preparation date was held, but the second trial was scheduled for January this year, as Vice-Chairman Lee demanded that “the case record is vast and needs time to review.”
However, at the beginning of this year, the trial was postponed due to the re-proliferation of the novel coronavirus infection (Corona 19) and the court’s regular personnel, and the trial was held again in about five months.
The 25th Division of the Criminal Agreement in charge of the trial is a parallel court consisting of three chief judges. Deputy Judge Park Jeong-je is the judge, and the chief judge is the doctor and the vice-president who draft the decision.
Also, on that day, the Seoul Central District Prosecutor’s Office Citizen’s Committee held a deputy deliberation committee to discuss whether to accept Lee’s request to convene an investigation deliberation committee. The Deputy Deliberation Committee is composed of 15 randomly selected citizen members of the prosecution.
If the Vice-Chairman’s request is valid, the case will be turned over to the Investigation Review Committee. The Investigation Review Committee is an organization that deliberates on the investigation process of cases that raise national suspicions or draws attention to society, and evaluates the legality of investigation results.
Earlier, in January of last year, the National Rights Commission requested an investigation by the prosecution after receiving a public interest report that Vice Chairman Lee had been routinely administered Propofol at a plastic surgery clinic.
Vice-Chairman Lee denied the charges, saying, “(Vice-Chairman Lee) received treatment at a hospital in the past according to the doctor’s professional opinion, and since then, due to personal circumstances, he has inevitable visited medical treatment, but illegal medication is not true.”
The plastic surgeon, who was previously accused of administering Propofol to Vice Chairman Lee, was sentenced to three years in prison at the first trial on charges of routinely administering Propofol to the conglomerate’s personnel.
Meanwhile, Vice Chairman Lee is serving in Seoul detention center after being sentenced to two years and six months in prison at a repatriation trial for the destruction of the Gukjeong Nongdan case in January.
/ Reporter Jo Kwon-hyung [email protected]
< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >